Renaissance Technologies’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.57M Sell
173,134
-150,433
-46% -$8.31M 0.01% 1079
2025
Q1
$15.6M Buy
323,567
+102,400
+46% +$4.95M 0.02% 771
2024
Q4
$8.54M Buy
221,167
+77,000
+53% +$2.97M 0.01% 1114
2024
Q3
$6.49M Sell
144,167
-153,300
-52% -$6.9M 0.01% 1283
2024
Q2
$10.3M Buy
297,467
+264,900
+813% +$9.18M 0.02% 900
2024
Q1
$942K Sell
32,567
-181,400
-85% -$5.25M ﹤0.01% 2526
2023
Q4
$4.91M Sell
213,967
-12,301
-5% -$282K 0.01% 1358
2023
Q3
$3.77M Sell
226,268
-163,999
-42% -$2.74M 0.01% 1465
2023
Q2
$10.8M Sell
390,267
-300,600
-44% -$8.3M 0.02% 982
2023
Q1
$15.9M Buy
690,867
+432,000
+167% +$9.94M 0.02% 845
2022
Q4
$2.82M Sell
258,867
-140,900
-35% -$1.54M ﹤0.01% 1860
2022
Q3
$3.37M Buy
399,767
+76,900
+24% +$648K ﹤0.01% 1690
2022
Q2
$2.55M Buy
322,867
+303,400
+1,559% +$2.4M ﹤0.01% 2016
2022
Q1
$461K Buy
+19,467
New +$461K ﹤0.01% 3248
2021
Q1
Sell
-35,797
Closed -$722K 3622
2020
Q4
$722K Sell
35,797
-300,903
-89% -$6.07M ﹤0.01% 2663
2020
Q3
$6.58M Sell
336,700
-195,600
-37% -$3.82M 0.01% 1408
2020
Q2
$9.4M Sell
532,300
-43,100
-7% -$761K 0.01% 1261
2020
Q1
$4.06M Sell
575,400
-42,724
-7% -$302K ﹤0.01% 1689
2019
Q4
$4.36M Buy
618,124
+63,024
+11% +$444K ﹤0.01% 1938
2019
Q3
$6.67M Buy
555,100
+42,800
+8% +$514K 0.01% 1641
2019
Q2
$6.2M Buy
512,300
+107,300
+26% +$1.3M 0.01% 1694
2019
Q1
$5.09M Buy
405,000
+65,200
+19% +$820K ﹤0.01% 1800
2018
Q4
$2.29M Sell
339,800
-197,400
-37% -$1.33M ﹤0.01% 2163
2018
Q3
$5.53M Buy
537,200
+58,900
+12% +$606K 0.01% 1739
2018
Q2
$3.21M Buy
478,300
+426,100
+816% +$2.86M ﹤0.01% 2034
2018
Q1
$448K Buy
+52,200
New +$448K ﹤0.01% 2951
2017
Q3
Sell
-25,989
Closed -$294K 3328
2017
Q2
$294K Buy
+25,989
New +$294K ﹤0.01% 2909